French pharma SaaS startup Biolevate raised a €30M Series A co-led by RAISE France and Orange Ventures, taking its total funding to €36M (Brock E.W. Turner/Axios)
Biolevate, a French pharma-focused SaaS startup, raised €30 million in Series A funding, CEO Joël Belafa tells Axios Pro exclusively.
We haven't written up this one. Techmeme has the full story — the link below goes straight to it.